Drug Manufacturers - General
Compare Stocks
2 / 10Stock Comparison
GRFS vs CSL
Revenue, margins, valuation, and 5-year total return — side by side.
Construction
GRFS vs CSL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - General | Construction |
| Market Cap | $7.11B | $15.29B |
| Revenue (TTM) | $7.51B | $4.98B |
| Net Income (TTM) | $401M | $725M |
| Gross Margin | 38.4% | 35.6% |
| Operating Margin | 17.0% | 20.1% |
| Forward P/E | 9.6x | 17.8x |
| Total Debt | $8.74B | $2.88B |
| Cash & Equiv. | $825M | $1.11B |
GRFS vs CSL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Grifols, S.A. (GRFS) | 100 | 44.4 | -55.6% |
| Carlisle Companies … (CSL) | 100 | 312.0 | +212.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GRFS vs CSL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GRFS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 1.12, yield 2.5%
- Rev growth 0.2%, EPS growth 147.8%, 3Y rev CAGR 6.0%
- Lower volatility, beta 1.12, current ratio 2.51x
CSL is the clearest fit if your priority is long-term compounding.
- 290.7% 10Y total return vs GRFS's -32.6%
- 0.3% revenue growth vs GRFS's 0.2%
- 14.6% margin vs GRFS's 5.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 0.3% revenue growth vs GRFS's 0.2% | |
| Value | Lower P/E (9.6x vs 17.8x) | |
| Quality / Margins | 14.6% margin vs GRFS's 5.3% | |
| Stability / Safety | Beta 1.12 vs CSL's 1.12, lower leverage | |
| Dividends | 2.5% yield, 2-year raise streak, vs CSL's 1.1% | |
| Momentum (1Y) | +18.9% vs CSL's -1.9% | |
| Efficiency (ROA) | 12.0% ROA vs GRFS's 2.0%, ROIC 20.6% vs 5.4% |
GRFS vs CSL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GRFS vs CSL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — GRFS and CSL each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GRFS is the larger business by revenue, generating $7.5B annually — 1.5x CSL's $5.0B. CSL is the more profitable business, keeping 14.6% of every revenue dollar as net income compared to GRFS's 5.3%. On growth, GRFS holds the edge at -0.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $7.5B | $5.0B |
| EBITDAEarnings before interest/tax | $1.6B | $1.1B |
| Net IncomeAfter-tax profit | $401M | $725M |
| Free Cash FlowCash after capex | $772M | $925M |
| Gross MarginGross profit ÷ Revenue | +38.4% | +35.6% |
| Operating MarginEBIT ÷ Revenue | +17.0% | +20.1% |
| Net MarginNet income ÷ Revenue | +5.3% | +14.6% |
| FCF MarginFCF ÷ Revenue | +10.3% | +18.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.6% | -4.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +40.0% | -3.1% |
Valuation Metrics
GRFS leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 12.6x trailing earnings, GRFS trades at a 42% valuation discount to CSL's 21.8x P/E. On an enterprise value basis, GRFS's 8.6x EV/EBITDA is more attractive than CSL's 14.3x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $7.1B | $15.3B |
| Enterprise ValueMkt cap + debt − cash | $16.4B | $17.1B |
| Trailing P/EPrice ÷ TTM EPS | 12.57x | 21.84x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.60x | 17.82x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 8.63x | 14.25x |
| Price / SalesMarket cap ÷ Revenue | 0.84x | 3.05x |
| Price / BookPrice ÷ Book value/share | 0.64x | 9.00x |
| Price / FCFMarket cap ÷ FCF | 8.07x | 15.75x |
Profitability & Efficiency
CSL leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CSL delivers a 34.5% return on equity — every $100 of shareholder capital generates $34 in annual profit, vs $5 for GRFS. GRFS carries lower financial leverage with a 1.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to CSL's 1.60x. On the Piotroski fundamental quality scale (0–9), GRFS scores 6/9 vs CSL's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +5.2% | +34.5% |
| ROA (TTM)Return on assets | +2.0% | +12.0% |
| ROICReturn on invested capital | +5.4% | +20.6% |
| ROCEReturn on capital employed | +6.4% | +18.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.15x | 1.60x |
| Net DebtTotal debt minus cash | $7.9B | $1.8B |
| Cash & Equiv.Liquid assets | $825M | $1.1B |
| Total DebtShort + long-term debt | $8.7B | $2.9B |
| Interest CoverageEBIT ÷ Interest expense | 2.05x | 11.06x |
Total Returns (Dividends Reinvested)
CSL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CSL five years ago would be worth $20,277 today (with dividends reinvested), compared to $4,978 for GRFS. Over the past 12 months, GRFS leads with a +18.9% total return vs CSL's -1.9%. The 3-year compound annual growth rate (CAGR) favors CSL at 22.1% vs GRFS's 4.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -9.0% | +14.2% |
| 1-Year ReturnPast 12 months | +18.9% | -1.9% |
| 3-Year ReturnCumulative with dividends | +13.6% | +81.9% |
| 5-Year ReturnCumulative with dividends | -50.2% | +102.8% |
| 10-Year ReturnCumulative with dividends | -32.6% | +290.7% |
| CAGR (3Y)Annualised 3-year return | +4.3% | +22.1% |
Risk & Volatility
Evenly matched — GRFS and CSL each lead in 1 of 2 comparable metrics.
Risk & Volatility
GRFS is the less volatile stock with a 1.12 beta — it tends to amplify market swings less than CSL's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSL currently trades 85.8% from its 52-week high vs GRFS's 75.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 1.12x |
| 52-Week HighHighest price in past year | $11.14 | $435.92 |
| 52-Week LowLowest price in past year | $7.08 | $293.43 |
| % of 52W HighCurrent price vs 52-week peak | +75.5% | +85.8% |
| RSI (14)Momentum oscillator 0–100 | 50.9 | 51.7 |
| Avg Volume (50D)Average daily shares traded | 705K | 386K |
Analyst Outlook
Evenly matched — GRFS and CSL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates GRFS as "Buy" and CSL as "Buy". For income investors, GRFS offers the higher dividend yield at 2.52% vs CSL's 1.12%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $408.75 |
| # AnalystsCovering analysts | 8 | 26 |
| Dividend YieldAnnual dividend ÷ price | +2.5% | +1.1% |
| Dividend StreakConsecutive years of raises | 2 | 37 |
| Dividend / ShareAnnual DPS | $0.18 | $4.19 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | +8.5% |
CSL leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). GRFS leads in 1 (Valuation Metrics). 3 tied.
GRFS vs CSL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is GRFS or CSL a better buy right now?
For growth investors, Carlisle Companies Incorporated (CSL) is the stronger pick with 0.
3% revenue growth year-over-year, versus 0. 2% for Grifols, S. A. (GRFS). Grifols, S. A. (GRFS) offers the better valuation at 12. 6x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate Grifols, S. A. (GRFS) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GRFS or CSL?
On trailing P/E, Grifols, S.
A. (GRFS) is the cheapest at 12. 6x versus Carlisle Companies Incorporated at 21. 8x. On forward P/E, Grifols, S. A. is actually cheaper at 9. 6x.
03Which is the better long-term investment — GRFS or CSL?
Over the past 5 years, Carlisle Companies Incorporated (CSL) delivered a total return of +102.
8%, compared to -50. 2% for Grifols, S. A. (GRFS). Over 10 years, the gap is even starker: CSL returned +290. 7% versus GRFS's -32. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GRFS or CSL?
By beta (market sensitivity over 5 years), Grifols, S.
A. (GRFS) is the lower-risk stock at 1. 12β versus Carlisle Companies Incorporated's 1. 12β — meaning CSL is approximately 0% more volatile than GRFS relative to the S&P 500. On balance sheet safety, Grifols, S. A. (GRFS) carries a lower debt/equity ratio of 115% versus 160% for Carlisle Companies Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — GRFS or CSL?
By revenue growth (latest reported year), Carlisle Companies Incorporated (CSL) is pulling ahead at 0.
3% versus 0. 2% for Grifols, S. A. (GRFS). On earnings-per-share growth, the picture is similar: Grifols, S. A. grew EPS 147. 8% year-over-year, compared to -38. 6% for Carlisle Companies Incorporated. Over a 3-year CAGR, GRFS leads at 6. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GRFS or CSL?
Carlisle Companies Incorporated (CSL) is the more profitable company, earning 14.
8% net margin versus 5. 3% for Grifols, S. A. — meaning it keeps 14. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CSL leads at 19. 9% versus 16. 4% for GRFS. At the gross margin level — before operating expenses — CSL leads at 35. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GRFS or CSL more undervalued right now?
On forward earnings alone, Grifols, S.
A. (GRFS) trades at 9. 6x forward P/E versus 17. 8x for Carlisle Companies Incorporated — 8. 2x cheaper on a one-year earnings basis.
08Which pays a better dividend — GRFS or CSL?
All stocks in this comparison pay dividends.
Grifols, S. A. (GRFS) offers the highest yield at 2. 5%, versus 1. 1% for Carlisle Companies Incorporated (CSL).
09Is GRFS or CSL better for a retirement portfolio?
For long-horizon retirement investors, Carlisle Companies Incorporated (CSL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
12), 1. 1% yield, +290. 7% 10Y return). Both have compounded well over 10 years (CSL: +290. 7%, GRFS: -32. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GRFS and CSL?
These companies operate in different sectors (GRFS (Healthcare) and CSL (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GRFS is a small-cap deep-value stock; CSL is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.